10398544 9827694 8145050 9550282 9874270 8816970 28478104 10415077 9307887 9797040 21672284 9185876 16764050 7843223 7836925 9191169 24582317 12959992 9416430 7532600 9003594 16306329 8635648 9230348 11078157 8664448 9543185 8760354 27324759 16263243 - Search Results

Year	Number of Results
1994	4
1995	11
1996	13
1997	18
1998	5
1999	9
2000	3
2003	2
2004	2
2005	3
2011	2
2012	1
2014	2
2015	2
2016	3
2017	1
2020	1
2023	1

1

Type 1 diabetes: the facts fit a deficient inhibitory signal given by MHC class II.

Gray DW. Gray DW. Diabetes Metab Res Rev. 1999 Jan-Feb;15(1):29-41. doi: 10.1002/(sici)1520-7560(199901/02)15:1<29::aid-dmrr5>3.0.co;2-z. Diabetes Metab Res Rev. 1999. PMID: 10398544 Review.

2

Macrophages and antioxidant status in the NOD mouse pancreas.

Papaccio G, De Luca B, Pisanti FA. Papaccio G, et al. J Cell Biochem. 1998 Dec 15;71(4):479-90. J Cell Biochem. 1998. PMID: 9827694

3

Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice.

Wogensen L, Lee MS, Sarvetnick N. Wogensen L, et al. J Exp Med. 1994 Apr 1;179(4):1379-84. doi: 10.1084/jem.179.4.1379. J Exp Med. 1994. PMID: 8145050 Free PMC article.

4

Effect of oral and intravenous insulin and glutamic acid decarboxylase in NOD mice.

Ramiya VK, Shang XZ, Wasserfall CH, Maclaren NK. Ramiya VK, et al. Autoimmunity. 1997;26(3):139-51. doi: 10.3109/08916939708994736. Autoimmunity. 1997. PMID: 9550282

5

Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis.

Gallichan WS, Kafri T, Krahl T, Verma IM, Sarvetnick N. Gallichan WS, et al. Hum Gene Ther. 1998 Dec 10;9(18):2717-26. doi: 10.1089/hum.1998.9.18-2717. Hum Gene Ther. 1998. PMID: 9874270

6

Antigen based therapies to prevent diabetes in NOD mice.

Ramiya VK, Shang XZ, Pharis PG, Wasserfall CH, Stabler TV, Muir AB, Schatz DA, Maclaren NK. Ramiya VK, et al. J Autoimmun. 1996 Jun;9(3):349-56. doi: 10.1006/jaut.1996.0047. J Autoimmun. 1996. PMID: 8816970

7

What can Sjögren's syndrome-like disease in mice contribute to human Sjögren's syndrome?

Peck AB, Nguyen CQ. Peck AB, et al. Clin Immunol. 2017 Sep;182:14-23. doi: 10.1016/j.clim.2017.05.001. Epub 2017 May 3. Clin Immunol. 2017. PMID: 28478104 Free PMC article. Review.

8

Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.

Gallichan WS, Balasa B, Davies JD, Sarvetnick N. Gallichan WS, et al. J Immunol. 1999 Aug 1;163(3):1696-703. J Immunol. 1999. PMID: 10415077

9

Benign versus destructive insulitis.

Kolb H. Kolb H. Diabetes Metab Rev. 1997 Sep;13(3):139-46. doi: 10.1002/(sici)1099-0895(199709)13:3<139::aid-dmr190>3.0.co;2-9. Diabetes Metab Rev. 1997. PMID: 9307887 Review. No abstract available.

10

Troglitazone prevents insulin dependent diabetes in the non-obese diabetic mouse.

Beales PE, Liddi R, Giorgini AE, Signore A, Procaccini E, Batchelor K, Pozzilli P. Beales PE, et al. Eur J Pharmacol. 1998 Sep 18;357(2-3):221-5. doi: 10.1016/s0014-2999(98)00574-3. Eur J Pharmacol. 1998. PMID: 9797040

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

80 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Results by year